H1074 Joint Program: Section on Neonatal Perinatal Medicine and Section on Advances in Therapeutics and Technology

Saturday, November 3
1:30 PM - 5:30 PM
Location: Windermere Ballroom Y, Hyatt Regency Orlando


Topic(s): Neonatology

Sponsor(s): Section on Neonatal Perinatal Medicine, Section on Advances in Therapeutics and Technology 

View full agenda here

This program will focus on drug therapeutics and emerging technologies. Topics to be covered include neonatologists’ roles in developing neonatal drugs and therapies; the regulatory approval process for new and established therapies; the role of the International Neonatal Consortium in reviewing therapies being applied to neonatal conditions; the use of stem cells to treat chronic lung injury and bronchopulmonary dysplasia; and an artificial placenta to provide cardiopulmonary support for extremely premature, low birthweight infants.

Jonathan M. Davis, MD, FAAP

Vice-Chair of Pediatrics, Chief of Newborn Medicine
The Floating Hospital for Children at Tufts Medical Center
Boston, Massachusetts

Presentation(s):

Send Email for Jonathan Davis

Alan W. Flake, MD

Professor of Surgery, University of Pennsylvania Perelman School of Medicine, Ruth and Tristram B. Colket Jr. Chair in Pediatric Surgery, Director of the Children's Center for Fetal Research, Vice Chair of Research Department of Surgery,
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania

Presentation(s):

Send Email for Alan Flake

Matthew Laughon, MD, MPH

Professor of Pediatrics
UNC Hospitals
Chapel Hill, North Carolina

Presentation(s):

Send Email for Matthew Laughon

Bernard Thebaud, PhD, MD

Professor of Pediatrics, University of Ottawa; Senior Scientist, Ottawa Hospital Research Institute; Neonatologist, Children's Hospital of Ontario; University of Ottawa Partnership Research Chair in Regenerative Medicine
Ottawa, Ontario, Canada

Presentation(s):

Send Email for Bernard Thebaud


Assets

H1074 Joint Program: Section on Neonatal Perinatal Medicine and Section on Advances in Therapeutics and Technology



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Joint Program: Section on Neonatal Perinatal Medicine and Section on Advances in Therapeutics and Technology

'

H1074 Joint Program: Section on Neonatal Perinatal Medicine and Section on Advances in Therapeutics and Technology

Saturday, November 3
1:30 PM - 5:30 PM
Location: Windermere Ballroom Y, Hyatt Regency Orlando


Topic(s): Neonatology

Sponsor(s): Section on Neonatal Perinatal Medicine, Section on Advances in Therapeutics and Technology 

View full agenda here

This program will focus on drug therapeutics and emerging technologies. Topics to be covered include neonatologists’ roles in developing neonatal drugs and therapies; the regulatory approval process for new and established therapies; the role of the International Neonatal Consortium in reviewing therapies being applied to neonatal conditions; the use of stem cells to treat chronic lung injury and bronchopulmonary dysplasia; and an artificial placenta to provide cardiopulmonary support for extremely premature, low birthweight infants.

'

Send Email for Joint Program: Section on Neonatal Perinatal Medicine and Section on Advances in Therapeutics and Technology

'

Attendees who have favorited this

' '

Bernard Thebaud, PhD, MD

Professor of Pediatrics, University of Ottawa; Senior Scientist, Ottawa Hospital Research Institute; Neonatologist, Children's Hospital of Ontario; University of Ottawa Partnership Research Chair in Regenerative Medicine
Ottawa, Ontario, Canada

Presentation(s):

'

Send Email for Bernard Thebaud